QSA offers a range of clinical research services from pre-trial to post-trial including core trial operations and advanced specialised analyses
The SuStain algorithm is an example of a new generation of machine learning models that can be used to predict personalised prognosis of patients with multiple sclerosis. ThThe utility of such models are to reduce the duration of clinical trials, specifically in progressive multiple sclerosis, to expedite drug development.
"Identifying multiple sclerosis subtypes using unsupervised machine learning and MRI data from various clinical trials. So instead of relying on our subjective judgement with clinical phenotypes maybe we should look at the MRI and be more objective.” - Dr. Brandon Beaber, Southern California Permanente Medical Group